THYSSENKRUPP NUCERA AG & CO. KGAA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.16 EUR | -2.96% |
|
-8.16% | -44.50% |
| Jun. 05 | INDEX-MONITOR: Tui and Rational expected in the MDax in June - Douglas in the SDax | DP |
| Jun. 04 | THYSSENKRUPP NUCERA : Bernstein gives a Buy rating | ZD |
| Sales 2024 * | 891M 957M | Sales 2025 * | 1.11B 1.19B | Capitalization | 1.32B 1.42B |
|---|---|---|---|---|---|
| Net income 2024 * | -29M -31.16M | Net income 2025 * | 21M 22.56M | EV / Sales 2024 * | 0.74 x |
| Net cash position 2024 * | 663M 712M | Net cash position 2025 * | 578M 621M | EV / Sales 2025 * | 0.67 x |
| P/E ratio 2024 * |
-45.1
x | P/E ratio 2025 * |
59.5
x | Employees | 855 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 23.96% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.05% | ||
| 1 week | -6.27% | ||
| Current month | -9.74% | ||
| 1 month | -18.71% | ||
| 3 months | -25.95% | ||
| 6 months | -33.01% | ||
| Current year | -43.25% |
1 week
10.46
11.30
1 month
10.4613.64
Current year
10.4618.55
1 year
10.4625.28
3 years
10.4625.28
5 years
10.4625.28
10 years
10.4625.28
| Managers | Title | Age | Since |
|---|---|---|---|
Werner Ponikwar
CEO | Chief Executive Officer | 54 | 21-12-31 |
| Director of Finance/CFO | 63 | 92-12-31 | |
Fulvio Federico
CTO | Chief Tech/Sci/R&D Officer | 57 | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 21-12-31 | |
Klaus Keysberg
BRD | Director/Board Member | 59 | 21-12-31 |
| Director/Board Member | 59 | 23-06-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-12 | 10.24 | -2.20% | 157 351 |
| 24-06-11 | 10.47 | -0.57% | 139,263 |
| 24-06-10 | 10.53 | -2.50% | 186,639 |
| 24-06-07 | 10.8 | -3.14% | 324,258 |
| 24-06-06 | 11.15 | 0.00% | 103,563 |
Delayed Quote Xetra, June 11, 2024 at 11:35 am EDT
More quotes
thyssenkrupp nucera AG & Co. KGaA, formerly Thyssenkrupp Uhde Chlorine Engineers Gmbh, is a Germany-based company, which operates as an electrolysis technology provider. The Company's business consists of the design, engineering and procurement of electrolysis technologies and the plants into which they are incorporated, as well as the provision of aftermarket services for existing plants. The Company provides green hydrogen solutions, Chlor-alkali solutions, and hydrochloric acid solutions.
Sector
Construction & Engineering
Calendar
2024-08-12
- Q3 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
10.47
EUR
Average target price
18.96
EUR
Spread / Average Target
+81.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -43.25% | 1.42B | |
| +11.54% | 10.62B | |
| +84.03% | 2.22B | |
| +32.14% | 2.03B | |
| -21.85% | 1.62B | |
| +17.02% | 1.06B | |
| -9.40% | 714M | |
| -10.15% | 622M | |
| -40.65% | 553M | |
| +24.00% | 520M |
- Stock Market
- Equities
- NCH2 Stock
